RXMatch enables Canadian community pharmacies - already within the patient's circle of care - to identify and engage potentially eligible patients for clinical trials. The pharmacy is always the initiator. No PHI is ever shared with RXMatch.
The pharmacy is always the initiator and identifier. RXMatch never contacts patients and never receives PHI.
No black boxes. Protocol criteria translate into transparent, auditable logic that runs locally inside the pharmacy.
Sits alongside the pharmacy's existing workflows. Some protocols may include patient surveys, but day-to-day staff disruption is kept minimal.
Every query, outreach and outcome is time-stamped and logged for trial oversight from day one.
Three capabilities, working together, to bring trial access to where patients actually are.
Medication logic, demographics, geography and exclusions translate into deterministic rules that run inside the pharmacy's own systems. RXMatch never receives PHI - only the resulting de-identified counts.
The pharmacy, as part of the patient's circle of care, sends mass communications to patients flagged as potentially matching the trial criteria. Patients who are interested respond - which is when the clinical coordination team at Rx4CT takes over for next steps.
Designed around the real workflows of community pharmacies. Minimal day-to-day staff disruption and no parallel system to manage - the clinical coordination team at Rx4CT handles patient engagement after the response.
A clear, rule-driven process the pharmacy runs from inside its own systems. Inclusion and exclusion criteria drive an individualized algorithm - no black boxes, and no PHI ever leaves the pharmacy.
Sponsor inclusion and exclusion criteria are translated into deterministic rules - medications, demographics, geography and exclusions - and shared with participating pharmacies.
The pharmacy runs the rules locally against its own records. Only de-identified eligibility counts surface to the sponsor - no PHI ever leaves the pharmacy's circle of care.
Onboarded pharmacies send mass communications to patients flagged as potentially matching the trial criteria - drawing on their existing circle-of-care relationship with each patient.
Patients who are interested respond. From that point, the clinical coordination team at Rx4CT contacts them directly for next steps - eligibility confirmation, trial informed consent, and investigator handoff.
Patient identification and outreach are always initiated by the pharmacy as part of the patient's existing circle of care. RXMatch never receives PHI - only de-identified counts and consent-verified outcomes - so every action stands up to trial-level oversight.
The pharmacy - already within the patient's circle of care - is always the identifier of potential matches and the sender of any communications. RXMatch never contacts patients directly. Patients who respond are then engaged by the clinical coordination team at Rx4CT.
Personal health information never leaves the pharmacy. RXMatch sees only de-identified eligibility counts and consent-verified outcomes - all outreach is logged and auditable inside the pharmacy's own systems.
Designed around Canadian privacy and clinical-trial governance - PIPEDA, provincial health-information legislation (PHIPA and equivalents), Health Canada requirements and REB oversight - to support responsible pharmacy-led identification.
No. RXMatch identifies potentially eligible patients based on the deterministic rules you supply. Final eligibility determination, informed consent for the trial itself, and enrollment all remain with the investigator and sponsor.
The pharmacy is already inside the patient's circle of care, so it is the pharmacy - not RXMatch - that identifies potential matches and sends out communications. There's no separate enrollment-style opt-in at the pharmacy step: onboarded pharmacies send mass communications to patients flagged as potentially matching trial criteria. Patients who are interested respond, and from that point the clinical coordination team at Rx4CT engages them directly for next steps - including any informed consent required by the trial itself.
No. RXMatch is designed to sit alongside real pharmacy workflows - not on top of them. The rule engine runs inside the pharmacy's own systems; staff are never asked to run surveys, push enrollment, or change how they care for patients at the counter.
No. Personal health information never leaves the pharmacy. The pharmacy runs the deterministic rules locally against its own records and shares back only de-identified eligibility counts and consent-verified outcomes. RXMatch is not a custodian of patient data.
RXMatch is designed around the Canadian regulatory environment: PIPEDA federally, provincial health-information legislation (such as PHIPA in Ontario and equivalents elsewhere), Health Canada requirements for clinical-trial conduct, REB oversight, and ICH-GCP principles.
Once trial criteria are defined, the rules are translated into a deterministic algorithm and deployed to participating pharmacies for local execution - typically in days, not months. De-identified eligibility counts surface immediately so sponsors can refine criteria with full transparency.
Get a walkthrough of how RXMatch translates your protocol into a pharmacy-led, circle-of-care recruitment engine - with Rx4CT handling clinical coordination on the back end. Usually in under 30 minutes.
